Clinical trials
Clinical trials help identify potential new treatments to improve people’s health and save lives. Our progress is due in large part to the important and tough scientific questions we set out to answer with our trials and collaborations.
Genventis’s mission is to discover, develop and deliver innovative therapies that improve the lives of patients.
We are deeply grateful to the patients, healthy volunteers, families, hospitals, and clinics who participate in our clinical trials. Their commitment makes it possible to advance our understanding of disease and develop potential therapies that may benefit patients worldwide.
Deciding to participate in a clinical trial is an important and personal choice. In most cases, the therapies being studied have not yet been approved by regulatory agencies, such as the U.S. Food and Drug Administration (FDA), and their potential benefits and risks are not fully known. By choosing to volunteer, you play a vital role in helping the medical community evaluate whether new investigational treatments are safe and effective.
About the clinical trial process
Clinical trials are a key part of the drug development process and our goal to:
Genventis is conducting multiple clinical trials in oncology, neurologic, immunologic, and other serious diseases to evaluate the safety and efficacy of our potential therapies. You can explore our current pipeline to learn more about our ongoing and upcoming clinical trials for specific conditions.
Clinical trials are a key part of the drug development process, and our goal is to ensure they are conducted with scientific rigor, patient safety, and transparency. Through these studies, we evaluate whether our investigational therapies are safe, effective, and capable of addressing serious unmet medical needs. Each trial helps us generate the high-quality data required to advance new treatments, support regulatory review, and ultimately improve outcomes for patients and families worldwide.
What are clinical trials?
Clinical trials are research studies with volunteers designed to learn more about how our bodies respond to potential new medicines or treatments. We’re grateful to the thousands of volunteers who participate in our clinical trials — making our research possible.
Reasons to consider participating in a clinical trial
Trial participants will:
-
Learn more about their health condition and take an active role in their own health care
-
Help future patients by advancing medical research
You’re never required to join or complete a clinical trial. Trials are volunteer-only, and you may leave a trial at any time.
Risks include:
-
Unwanted side effects
-
The treatment may not work
-
You may not receive the new treatment being studied
-
Extra time and attention needed for trial-related tasks and visits
There are clinical trials in progress
Our medical advances can only happen through the efforts of many people, especially those who volunteer for clinical trials. They’re our partners in research.
Find a trial
Expanded Access Programs (EAP)
Participation in clinical trials is a primary route by which patients get access to investigational medicines and contribute to the collection of safety and efficacy data needed to support regulatory approval worldwide. For patients with a serious or life-threatening condition who are ineligible or unable to participate in a clinical trial, use of an expanded access program may be an option.
Read about our EAP program
Policies and perspectives
We’re committed to disclosing balanced, complete and accurate information about our registered clinical trials of marketed products, regardless of outcome.
Read more
We're committed to diversity in clinical trials
We’re committed to disclosing balanced, complete and accurate information about our registered clinical trials of marketed products, regardless of outcome.
The four phases of clinical trials
Clinical trials require four phases, in addition to government review and approval, to ensure the treatment being studied is safe and effective. Each phase answers a different set of questions. See our infographic on how we take a research study from trial to treatment.
Clinical trials take time and resources
-
A treatment may take several years to move from a phase 1 trial to government approval for doctors to prescribe it
-
Clinical trials require financial investment from sponsors. Genventis is the sponsor of a variety of clinical trials for various diseases and conditions
-
Thousands of people in many countries contribute to clinical trials, including patients, researchers, health care professionals and support staff
Patient Resources
Generalized Myasthenia Gravis:
Systemic Lupus Erythematosus:
You may also be interested in
Patients
Clinical Trials
Science & Innovation
Pipeline
